Some common heterocyclic compound, 1120-16-7, name is Dodecanamide, molecular formula is C12H25NO, traditional synthetic route has been very mature, but the traditional synthetic route has various shortcomings, such as complicated route, low yield, poor purity, etc, below Introduce a new synthetic route. Computed Properties of C12H25NO
A flask was charged with N-(7-chloro-7,8-dihydro-1,8- naphthyridin-2yl)dodecanamide (6) (15.6 g, 42.8mmol), dodecanamide (10.3 g, 51.3mmol), Pd(OAc)2 (593 mg, 2.6 mmol), Xantphos (3.3 g, 5.8mmol), K2CO3 (5.9 g, 42.8mmol), and dry dioxane (250 mL). Oven-dried molecular sieves (4) were added and the mixture was stirred overnight at room temperature under Ar. Subsequently, the mixture was heated to 80 C and stirred overnight under Ar. After cooling to room temperature, the mixture was filtered and the residue was rinsed with CHCl3. Recrystallization in ethanol and purification by flash chromatography (80% CHCl3/20% EtOAc) yielded the product as a white solid (16.5 g, 73%). 1HNMR (400 MHz, CDCl3): 8.42 (d, 2H, J = 8.8 Hz, Ar), 8.14 (d, 2H, J = 8.8 Hz, Ar), 8.12 (bs, 2H, NH), 2.47 (t, 4H, J = 7.6 Hz, O=C-CH2), 1.56 (m, 4H, J = 8.0, 7.6 Hz, O=C-CH2-CH2), 1.26 (m, 32H, alkyl-CH2), 0.88 (t, 6H, alkyl-CH3). 13CNMR (100 MHz, CDCl3): 172.2, 153.74, 138.98, 113.34, 110.01, 76.75, 38.13, 31.90, 29.60, 29.44, 29.33, 29.15, 25.29, 22.68, 14.12. MALDI-ToF MS: calculated for C32H52N4O2 524.78, observed m/z 525.43 [M + H+], 1087.79 [dimer + K+]. Elemental analysis: calculated for C32H52N4O2: C, 73.24; H, 9.99; N, 10.68; O, 6.10%. Found: C, 73.35; H, 9.59; N, 10.26%.
These compound has a wide range of applications. It is believed that with the continuous development of the source of the synthetic route 1120-16-7, its application will become more common.
Reference:
Article; Teunissen, Abraham J.P.; Van Der Haas, Roy J.C.; Vekemans, Jef A.J.M.; Palmans, Anja R.A.; Meijer; Bulletin of the Chemical Society of Japan; vol. 89; 3; (2016); p. 308 – 314;,
Amide – Wikipedia,
Amide – an overview | ScienceDirect Topics